Published in Prog Brain Res on January 01, 1986
Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol (1997) 2.70
Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry (2005) 2.29
Turner phenotype with pelvic kidney and other unusual abnormalities. JAMA (1970) 1.80
Pyramidical model of schizophrenia. Schizophr Bull (1990) 1.74
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59
Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci (2002) 1.56
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol (1998) 1.51
Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography. Eur J Nucl Med (1994) 1.42
Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiatry (1994) 1.40
[Analysis of intensity of post-stroke depression and its relationship with the cerebral lesion location]. Med Clin (Barc) (1997) 1.39
A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response. Br J Psychiatry (1980) 1.38
The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab (1985) 1.37
Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med (2007) 1.31
Adoption study supporting genetic transmission in manic--depressive illness. Nature (1977) 1.27
DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol (1999) 1.25
Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology (2001) 1.25
Polymorphic DNA marker on X chromosome and manic depression. Lancet (1987) 1.21
24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab (1987) 1.18
Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol (1999) 1.18
Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry (2005) 1.17
EEG sleep patterns in man: a twin study. Electroencephalogr Clin Neurophysiol (1989) 1.16
Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett (1996) 1.16
Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry (2001) 1.11
Evidence for X-linkage in the transmission of manic-depressive illness. JAMA (1972) 1.10
Computer-aided sleep staging in clinical environment. Neuropsychobiology (1988) 1.08
Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol (1993) 1.06
Linkage studies with X-chromosome markers in bipolar (manic-depressive) and unipolar (depressive) illnesses. Biol Psychiatry (1974) 1.03
A rhythmic movement disorder in REM sleep: a case report. Sleep (1994) 1.03
Rubidium: biochemical, behavioral, and metabolic studies in humans. Am J Psychiatry (1973) 1.00
Linkage analysis of families with bipolar illness and chromosome 18 markers. Biol Psychiatry (1996) 1.00
Morbidity risks in subtypes of unipolar depressive illness: differences between early and late onset forms. Br J Psychiatry (1981) 1.00
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology (1998) 0.99
Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis. Br J Psychiatry (1980) 0.99
Assessing the role of X-linked inheritance in bipolar-related major affective disorder. J Psychiatr Res (1986) 0.99
A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder. Mol Psychiatry (2003) 0.98
Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol Dis (1995) 0.97
The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry (1994) 0.97
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur Neuropsychopharmacol (2002) 0.97
Morbidity risk and genetic transmission in manic-depressive illness. Am J Hum Genet (1974) 0.96
Sleep spindle activity changes in patients with affective disorders. Sleep (1987) 0.94
Cerebrospinal fluid neurophysins in affective illness and in schizophrenia. Eur Arch Psychiatry Neurol Sci (1984) 0.93
Psychosocial predictors of major affective recurrences in bipolar disorder: a 4-year longitudinal study of patients on prophylactic treatment. Acta Psychiatr Scand (1996) 0.92
Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects. Psychiatry Res (2001) 0.92
Brain glucose metabolism in borderline personality disorder. J Psychiatr Res (1998) 0.91
Circadian and sleep-related endocrine rhythms in schizophrenia. Arch Gen Psychiatry (1991) 0.91
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsychobiology (2000) 0.89
Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry (1997) 0.89
Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee. Int Clin Psychopharmacol (1999) 0.89
L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. Br J Psychiatry (1983) 0.88
A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression. Mol Psychiatry (2004) 0.88
Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry (1973) 0.88
Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep (1995) 0.88
The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry (1973) 0.88
Accuracy of the family history method in affective illness. Comparison with direct interviews in family studies. Arch Gen Psychiatry (1975) 0.88
EEG sleep studies in patients with generalized anxiety disorder. Psychiatry Res (1988) 0.87
Manic-depressive illness: linkage with the Xg blood group. Am J Psychiatry (1973) 0.87
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord (2000) 0.87
Association between novelty-seeking and the dopamine D3 receptor gene in bipolar patients: a preliminary report. Am J Med Genet (1998) 0.87
Genetic history as a predictor of lithium response in manic-depressive illness. Lancet (1972) 0.86
Distribution of delta activity across nonrapid eye movement sleep episodes in healthy young men. Sleep (1997) 0.86
Temperament and Character Inventory (TCI) personality profile and sub-typing in alcoholic patients: a controlled study. Alcohol Alcohol (2001) 0.86
Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci (1985) 0.85
Multiple-threshold transmission of affective disorders. Arch Gen Psychiatry (1981) 0.85
Linkage analysis of bipolar illness with X-chromosome DNA markers: a susceptibility gene in Xq27-q28 cannot be excluded. Am J Med Genet (1994) 0.85
Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry (2001) 0.85
Social adjustment of remitted bipolar and unipolar out-patients. A comparison with age- and sex-matched controls. Br J Psychiatry (1991) 0.85
Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness. J Affect Disord (1980) 0.85
Genetic determinants of EEG sleep: a study in twins living apart. Electroencephalogr Clin Neurophysiol (1991) 0.85
Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiatry (1991) 0.84
Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr (1995) 0.84
Relationship between schizoaffective illness and affective disorders or schizophrenia. Morbidity risk and genetic transmission. J Affect Disord (1980) 0.84
Age at onset in bipolar-related major affective illness: clinical and genetic implications. J Psychiatr Res (1983) 0.84
Age-of-onset and genetic transmission in affective disorders. Acta Psychiatr Scand (1981) 0.84
Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study. J Neuroimaging (1995) 0.84
Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr Res (2001) 0.84
Suicidal behaviour in major depressive illness. Acta Psychiatr Scand (1985) 0.84
Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry (2002) 0.83
Social adjustment and the course of affective illness: a one-year controlled longitudinal study involving bipolar and unipolar outpatients. Depress Anxiety (1998) 0.83
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. J Affect Disord (1999) 0.83
The age factor in depressive illness: some genetic considerations. J Gerontol (1976) 0.83
Social adjustment and self-esteem of bipolar patients: a multicentric study. J Affect Disord (2004) 0.83
Manic-depressive illness: a comparative study of patients with and without a family history. Br J Psychiatry (1972) 0.83
Clinical and psychosocial predictors of recurrence in recovered bipolar and unipolar depressives: a one-year controlled prospective study. Psychiatry Res (1997) 0.83
Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. Compr Psychiatry (1999) 0.82
5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait. Am J Med Genet (2000) 0.82
A collaborative study of genetic linkage of bipolar manic-depressive illness and red/green colorblindness. A project of the biological psychiatry collaborative program of the world health organization. Acta Psychiatr Scand (1980) 0.82
Color blindness linkage to bipolar manic-depressive illness. New evidence. Arch Gen Psychiatry (1979) 0.82
Lithium accumulation in erythrocytes of manic-depressive patients: an in vivo twin study. Br J Psychiatry (1978) 0.82
Differential fertility in bipolar affective illness. J Affect Disord (1982) 0.81
Automated sleep scoring: a comparative reliability study of two algorithms. Electroencephalogr Clin Neurophysiol (1987) 0.81
Regional cerebral blood flow and lateralized hemispheric dysfunction in depression. Br J Psychiatry (1983) 0.81
Mirtazapine is more effective than trazodone: a double-blind controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol (1995) 0.81
Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response. Neuropsychobiology (1984) 0.81
Simultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patients. Neuropsychobiology (1982) 0.81
Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder. Psychiatr Genet (1999) 0.80
ACTH, cortisol and growth hormone 24-hour profiles in major depressive illness. Acta Psychiatr Belg (1986) 0.80
Sleep EEG variables in young schizophrenic and depressive patients. Biol Psychiatry (1988) 0.80
The 24-hour profile of plasma prolactin in men with major endogenous depressive illness. Arch Gen Psychiatry (1989) 0.80
No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism. Psychiatry Res (1997) 0.80